Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Hesperidin

Hesperidin

520-26-3

DISCOVER
Irganox MD 1024

Irganox MD 1024

32687-78-8

DISCOVER
Heroine

Heroine

561-27-3

DISCOVER
Hexestrol

Hexestrol

84-16-2

DISCOVER
Hexestrol dipropionate

Hexestrol dipropionate

4825-53-0

DISCOVER
Haloperidol

Haloperidol

52-86-8

DISCOVER
Homatoprine methylbromide

Homatoprine methylbromide

80-49-9

DISCOVER
Hydrochlorothiazid

Hydrochlorothiazid

58-93-5

DISCOVER
10,11-Dihydro-10-Hydroxycarbamazepine

10,11-Dihydro-10-Hydroxycarbamazepine

29331-92-8

DISCOVER
alpha-Hydroxyalprazolam

alpha-Hydroxyalprazolam

37115-43-8

DISCOVER
alpha-OH Metoprolol (Mix of Diastereomers)

alpha-OH Metoprolol (Mix of Diastereomers)

56392-16-6

DISCOVER
rac-4-Hydroxy Propranolol HCl

rac-4-Hydroxy Propranolol HCl

14133-90-5

DISCOVER